URSO 250 Drug Patent Profile

✉ Email this page to a colleague

When do Urso 250 patents expire, and what generic alternatives are available?

Urso 250 is a drug marketed by Allergan and is included in one NDA.

The generic ingredient in URSO 250 is ursodiol. There are eight drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the ursodiol profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Urso 250

A generic version of URSO 250 was approved as ursodiol by EPIC PHARMA on March 14^th, 2000.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for URSO 250?
What are the global sales for URSO 250?
What is Average Wholesale Price for URSO 250?

Summary for URSO 250

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	2
Raw Ingredient (Bulk) Api Vendors:	93
Patent Applications:	4,631
What excipients (inactive ingredients) are in URSO 250?	URSO 250 excipients list
DailyMed Link:	URSO 250 at DailyMed

Drug patent expirations by year for URSO 250

Pharmacology for URSO 250

Drug Class	Bile Acid

US Patents and Regulatory Information for URSO 250

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Allergan	URSO 250	ursodiol	TABLET;ORAL	020675-001	Dec 10, 1997	AB	RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for URSO 250

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Allergan	URSO 250	ursodiol	TABLET;ORAL	020675-001	Dec 10, 1997	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for URSO 250

See the table below for patents covering URSO 250 around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
France	2607005	COMPOSITIONS PHARMACEUTIQUES CONTENANT DE L'ACIDE URSODESOXYCHOLIQUE	⤷ Sign Up
Japan	S63141929	MEDICINAL COMPOSITION CONTAINING ULSODEOXYCHOLIC ACID	⤷ Sign Up
European Patent Office	0269516		⤷ Sign Up
Canada	1318590	COMPOSITIONS PHARMACEUTIQUES CONTENANT DE L'ACIDE URSODESOXYCHOLIQUE (PHARMACEUTICAL COMPOSITIONS CONTAINING URSODEOXYCHOLIC ACID)	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for URSO 250

Pharmacology for URSO 250

Make Better Decisions: Try a trial or see plans & pricing